Finally, several strategies for inhibition of HGF or HGF-induced intracellular signaling are currently being developed [121,122], but to the best of our knowledge, this strategy has not been investigated in clinical trials for patients with acute GVHD. Here, HGF is linked to acute graft versus host disease.